top of page
Abstract Background

Upcoming Webinars

Webinar: Recurrent Ovarian Cancer

During this webinar, participants will review various cases, including typical and long-term trajectories of high-grade serous carcinoma, as well as cases of clear cell carcinoma and mucinous carcinoma, with an additional case focusing on low-grade serous carcinoma. Evaluate the implications of recurrent high-grade serous ovarian carcinoma based on the recurrence-free interval post-chemotherapy and analyze treatment options according to platinum sensitivity or resistance. Analyze the current evidence supporting therapeutic approaches for mucinous ovarian carcinoma. Identify and apply appropriate treatment strategies for patients with recurrent low-grade serous ovarian cancer.

Webinaire : Cancer de l’ovaire récidivant

Webinaire : Cancer de l’ovaire récidivant

Play Video

Webinar on Obesity

20:00 - 20:10 Welcome Address & Learning Objectives Review obesity as a chronic disease. Discuss the stigma surrounding overweight and obesity. Neda Nasseri Pharmacist, Member of the Advisory Committee, Obesity Matters 20:10 - 20:30 Childhood Obesity Analyzing the relationship between childhood obesity and future risks of gynecologic cancer. Learning Objectives: Discuss childhood obesity and its underlying pathophysiology. Examine the importance of childhood obesity prevention and its impact on adult health, particularly cancer incidence. Review treatment goals and challenges for childhood obesity. Explain available therapeutic approaches. Julie St-Pierre Pediatrician, Maison de Santé Prévention 20:30 - 20:50 Impact of Obesity on Oncologic Treatments for Gynecologic Cancer Patients Evaluating the complexities and challenges of performing gynecologic oncology surgeries on patients with obesity. Learning Objectives: Examine pre-, intra-, and postoperative challenges associated with increased BMI. Identify strategies to improve the safety of surgical care for patients with high BMI. Discuss medical/systemic treatments and their adaptations for routine care in patients with obesity. Susie Lau – Gynecologic Oncologist, McGill University Health Centre Laurence Bernard – Gynecologic Oncologist, McGill University Health Centre 20:50 - 21:10 Medical Treatment in Adulthood Assessing the effectiveness of medical interventions for obesity and their implications for gynecologic oncology. Learning Objectives: Explore the link between obesity and gynecologic cancers. Define the role of obesity treatment in cancer survivorship and associated controversies. Provide an overview of obesity treatment options for patients in Canada. Marie-Hélène Auclair – Gynecologic Oncologist 21:10 - 21:35 Q&A Session

Obésité infantile

Obésité infantile
Obésité infantile
28:16
Play Video

Obésité infantile

Webinaire sur l'obésité - vidéo complète
02:04:10
Play Video

Webinaire sur l'obésité - vidéo complète

Impact de l'obésité sur les traitements oncologiques des patientes atteintes de cancers gynécologiques
22:01
Play Video

Impact de l'obésité sur les traitements oncologiques des patientes atteintes de cancers gynécologiques

Obesity Matters
15:39
Play Video

Obesity Matters

Webinaire_Obesite_Q&A
18:29
Play Video

Webinaire_Obesite_Q&A

Traitement médical à l'âge adulte
18:45
Play Video

Traitement médical à l'âge adulte

Impact de l'obésité sur les traitements oncologiques des patientes atteintes de cancers gynécologiques
12:21
Play Video

Impact de l'obésité sur les traitements oncologiques des patientes atteintes de cancers gynécologiques

Rare Complications of Immunotherapy in Cancer Treatment

Join Our Upcoming Webinar! Designed specifically for healthcare professionals using immunotherapy to treat their patients, this session will explore the rare complications associated with these treatments and provide practical guidance through case studies and evidence-based practices. Learn to recognize and manage uncommon issues, identify molecules that mimic immune-related complications, and determine when urgent consultation is necessary. This essential training aims to enhance expertise in immunotherapy, ultimately leading to better patient outcomes. Learning Objectives: Familiarize yourself with rare complications of immunotherapy in gynecologic cancer treatment. Identify molecules that may mimic immune-oncology complications. Recognize urgent conditions requiring immediate consultation with a hematologist. Wednesday, June 5 | Online This activity is an accredited group learning activity (Section 1) as defined by the Maintenance of Certification (MOC) Program of the Royal College of Physicians and Surgeons of Canada. It is also recognized as a professional development activity (Category A) by the Collège des médecins du Québec. You may claim up to 1.5 hours in Section 1 / recognized professional development activity (Category A). Participants should claim credit in accordance with the duration of their participation.

Introduction

Introduction
Introduction
28:15
Play Video

Introduction

Webinaire sur l'immunotherapie - Cas 1
13:42
Play Video

Webinaire sur l'immunotherapie - Cas 1

Webinaire sur l'immunotherapie - Cas 2
14:30
Play Video

Webinaire sur l'immunotherapie - Cas 2

Webinaire sur l'immunotherapie - Cas 3
17:56
Play Video

Webinaire sur l'immunotherapie - Cas 3

bottom of page